Exploring the role of anti-angiogenic therapies in prostate cancer: results from the phase 3 trial of sunitinib.

TitleExploring the role of anti-angiogenic therapies in prostate cancer: results from the phase 3 trial of sunitinib.
Publication TypeJournal Article
Year of Publication2014
AuthorsBeltran H, Kaur G, de España CGarcías, Tagawa ST
JournalAsian J Androl
Volume16
Issue4
Pagination568-9
Date Published2014 Jul-Aug
ISSN1745-7262
KeywordsAntineoplastic Combined Chemotherapy Protocols, Humans, Male, Prednisone, Prostatic Neoplasms
DOI10.4103/1008-682X.127822
Alternate JournalAsian J. Androl.
PubMed ID24875818
PubMed Central IDPMC4104084